Sinopharm Group Co Ltd
HKEX:1099
Sinopharm Group Co Ltd
HKEX:1099
Price:
20.05 HKD
2.19%
Updated:
May 6, 2024
Sinopharm Group Co Ltd
Cash from Financing Activities
|
Sinopharm Group Co Ltd
Cash from Financing Activities Peer Comparison
Comparables:
S
601607
600998
C
600511
000963
C
000028
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Financing Activities
-¥6.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Financing Activities
¥231.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Financing Activities
-¥3.9B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Financing Activities
-¥632.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Financing Activities
-¥1.2B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Cash from Financing Activities
-¥2.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-31%
|
See Also
What is Sinopharm Group Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-6.9B
CNY
-6.9B
CNY
Based on the financial report for Jun 30, 2023, Sinopharm Group Co Ltd's Cash from Financing Activities amounts to -6.9B CNY.
What is Sinopharm Group Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-71%
-71%
Over the last year, the Cash from Financing Activities growth was -71%.
You don't have any saved screeners yet
